Literature DB >> 15006356

A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors.

Yiwen Jan1, Michelle Matter, Jih-tung Pai, Yen-Liang Chen, Jan Pilch, Masanobu Komatsu, Edgar Ong, Minoru Fukuda, Erkki Ruoslahti.   

Abstract

A delicate balance of signals regulates cell survival. One set of these signals is derived from integrin-mediated cell adhesion to the extracellular matrix (ECM). Loss of cell attachment to the ECM causes apoptosis, a process known as anoikis. In searching for proteins involved in cell adhesion-dependent regulation of anoikis, we identified Bit1, a mitochondrial protein that is released into the cytoplasm during apoptosis. Cytoplasmic Bit1 forms a complex with AES, a small Groucho/transducin-like enhancer of split (TLE) protein, and induces cell death with characteristics of caspase-independent apoptosis. Cell attachment to fibronectin counteracts the apoptotic effect of Bit1 and AES. Increasing Bit1 expression enhances anoikis, while suppressing the expression reduces it. Thus, we have elucidated an integrin-controlled pathway that is, at least in part, responsible for the cell survival effects of cell-ECM interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006356     DOI: 10.1016/s0092-8674(04)00204-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  Transducin-like enhancer of Split-1 (TLE1) combines with Forkhead box protein G1 (FoxG1) to promote neuronal survival.

Authors:  Somasish Ghosh Dastidar; Sriram Narayanan; Stefano Stifani; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

2.  Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Cheryl Chalberg; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  The organelle proteome of the DT40 lymphocyte cell line.

Authors:  Stephanie L Hall; Svenja Hester; Julian L Griffin; Kathryn S Lilley; Antony P Jackson
Journal:  Mol Cell Proteomics       Date:  2009-01-30       Impact factor: 5.911

4.  Bit1-a novel regulator of astrocyte function during retinal development: proliferation, migration, and paracrine effects on vascular endothelial cell.

Authors:  Yan Liu; Jiali Ji; Wanyu Shao; Min Luo; Bo Ma
Journal:  Hum Cell       Date:  2019-07-31       Impact factor: 4.174

5.  Myxoma virus M11L blocks apoptosis through inhibition of conformational activation of Bax at the mitochondria.

Authors:  Jin Su; Gen Wang; John W Barrett; Timothy S Irvine; Xiujuan Gao; Grant McFadden
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.

Authors:  Naser M Ali; Stefania Niada; Anna T Brini; Mark R Morris; Sathishkumar Kurusamy; Abdullah Alholle; David Huen; Cristina R Antonescu; Franck Tirode; Vaiyapuri Sumathi; Farida Latif
Journal:  J Pathol       Date:  2018-12-27       Impact factor: 7.996

7.  Application of a proapoptotic peptide to intratumorally spreading cancer therapy.

Authors:  Renwei Chen; Gary B Braun; Xiuquan Luo; Kazuki N Sugahara; Tambet Teesalu; Erkki Ruoslahti
Journal:  Cancer Res       Date:  2012-12-17       Impact factor: 12.701

Review 8.  AES/GRG5: more than just a dominant-negative TLE/GRG family member.

Authors:  Brandon Beagle; Gail V W Johnson
Journal:  Dev Dyn       Date:  2010-11       Impact factor: 3.780

9.  Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD.

Authors:  Brandon Beagle; Gail V W Johnson
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.